Coal India, Dr Lal PathLabs, CARE Ratings and Sasken Technologies stocks are in focus as they are going to be ex-dividend after their recent interim dividend announcements. These stocks will become ex-dividend on November 5, 2024. Coal India paid an interim dividend of Rs 15.75 per share. Similarly, Dr Lal PathLabs and CARE Ratings have declared interim dividends of Rs 6 and Rs 7 per share respectively, both with a record date of November 5.
What is this ex-date? What is its importance- To avail the dividend, the purchase of shares must be completed before the ex-date. If you buy shares on the ex-date, you will not get the benefit of that corporate action.
At the same time, also keep in mind that investment in stock is not done only on the basis of corporate action. You should get information about these stocks from your trusted investment advisor and buy these stocks only when you get a positive trend for the future. (Big Orders Win: Shares rose by more than Rs 200 in falling market - price doubled in a year) Sasken Technologies has also declared an interim dividend of Rs 12 per share for its shareholders, the record date of which is November 5, 2024. Stock Split Stock Split - Systematics Corporate Services and Premier Polyfilm will also trade on ex-date from November 5 after the announcements of stock split. According to the exchange filing, Systematics Corporate Services has announced to bring shares with a face value of Rs 10 to shares with a face value of Rs 1. Premier Polyfilm has also announced a similar split. Shares with a face value of Rs 5 will now be worth Rs 1. Besides, stocks of Colgate-Palmolive (India), Manappuram Finance, Patanjali Foods, Oberoi Realty and Kajaria Ceramics will also be in focus today as they have gone ex-dividend after announcing dividends of Rs 24, Rs 0.25, Rs 8, Rs 2 and Rs 5 respectively for their shareholders. Disclaimer: The views or advice given on CNBC TV18 Hindi/CNBC-Awaaz are the personal views of the experts, brokerage firms. The website or the management is not responsible for it. Consult your financial advisor or certified expert before investing.
--Advertisement--